Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 64 Neoplasms 8 Sarcoma 6 Ovarian Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Sarcoma, Ewing 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Glioma 4 Carcinoma, Non-Small-Cell Lung 4 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Prostatic Neoplasms 3 Osteosarcoma 3 Neuroblastoma 3 Melanoma 3 Medulloblastoma 3 Lymphoma 3 Liposarcoma 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Wilms Tumor 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lung Neoplasms 2 Kidney Neoplasms 2

Interventions

Temozolomide 154 Bevacizumab 88 Radiotherapy 75 Radiation 23 Magnetic Resonance Spectroscopy 23 Lomustine 18 Irinotecan 18 pembrolizumab 17 Surgical Procedures, Operative 16 Carmustine 16 Erlotinib Hydrochloride 12 Nivolumab 11 Specimen Handling 10 Aminolevulinic Acid 10 sargramostim 9 Thalidomide 9 Chemotherapy, Adjuvant 9 Carboplatin 9 Drug Therapy 8 Immunoglobulin G 7 Filgrastim 7 Etoposide 7 Disulfides 7 Cilengitide 7 Sunitinib 6 Sorafenib 6 O(6)-benzylguanine 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × palbociclib × Clear all

NCT01227434 2015-07-17

PD0332991

University of California, San Francisco

Phase 2 Terminated

23 enrolled 8 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡